SuperworthVera Therapeutics market cap VERA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $2B
- Highest close in our data
- $3.4B
- Dec 2025
Vera Therapeutics is worth $2B at the close on Oct 23, 2026, at $27.99 a share.
That is up 8% over the last year and up 390% over five years.
Its highest close in our data was $3.4B in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2B | $2B | $3.2B | −41% |
| 2025 | $3.4B | $1.2B | $3.4B | +31% |
| 2024 | $2.6B | $663.4M | $3.2B | +284% |
| 2023 | $683.4M | $151.6M | $821.7M | +28% |
| 2022 | $535.2M | $359.3M | $625.5M | −6% |
| 2021 | $568.5M | $296.2M | $663.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Vera Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VERAVera Therapeutics | $2B |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| NRIXNurix Therapeutics | $2.8B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OMEROmeros | $1.2B |
| OGNOrganon | $3.6B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| Peer median | $1.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Vera Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.